[1] European Association for the Study of the Liver. EASL Clinical Practice Guidelines on acute-on-chronic liver failure. J Hepatol, 2023, 79(2):461-491. [2] de Haan J, Termorshuizen F, de Keizer N, et al. One-year transplant-free survival following hospital discharge after ICU admission for ACLF in the Netherlands. J Hepatol, 2024, 81(2):238-247. [3] Li J, Liang X, Jiang J, et al. PBMC transcriptomics identifies immune-metabolism disorder during the development of HBV-ACLF. Gut, 2022, 71(1):163-175. [4] Abbas N, Rajoriya N, Elsharkawy AM, et al. Acute-on-chronic liver failure (ACLF) in 2022: have novel treatment paradigms already arrived. Expert Rev Gastroenterol Hepatol, 2022, 16(7):639-652. [5] Xiao L, Chen J, Zhao S, et al. The 90-day survival threshold: a pivotal determinant of long-term prognosis in HBV-ACLF patients - insights from a prospective longitudinal cohort study. Adv Sci (Weinh), 2024, 11(16):e2304381. [6] 中华医学会感染病学分会肝衰竭与人工肝学组;中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊治指南(2018年版).实用肝脏病杂志,2019,22(2):164-171. [7] 中华医学会呼吸病学分会.医院获得性肺炎诊断和治疗指南(草案).中华结核和呼吸杂志,1999,22(4):201-202. [8] Kim KM, Shim SG, Sinn DH, et al. Child-Pugh, MELD, MELD-Na, and ALBI scores: which liver function models best predicts prognosis for HCC patient with ascites? Scand J Gastroenterol, 2020, 55(8):951-957. [9] Ngu NLY, Flanagan E, Bell S, et al. Acute-on-chronic liver failure: Controversies and consensus. World J Gastroenterol, 2023, 29(2):232-240. [10] Mezzano G, Juanola A, Cardenas A, et al. Global burden of disease: acute-on-chronic liver failure, a systematic review and meta-analysis. Gut, 2022, 71(1):148-155. [11] Zhang Y, Tan W, Wang X, et al. Metabolic biomarkers significantly enhance the prediction of HBV-related ACLF occurrence and outcomes. J Hepatol, 2023, 79(5):1159-1171. [12] Br VK, Sarin SK. Acute-on-chronic liver failure: Terminology, mechanisms and management. Clin Mol Hepatol, 2023, 29(3):670-689. [13] 邓珂欣,罗红春.常用血液学指标评定ACLF患者并发细菌感染和预后价值研究.实用肝脏病杂志,2023,26(2):242-245. [14] 郭北辰,李雨韩,陈蕊,等.MELD 3.0、MELD和MELD-Na评分对ACLF患者短期预后的评估价值.临床肝胆病杂志,2023,39(11):2635-2642. [15] Jadaun SS, Sharma S, Madhusudhan KS, et al. Spectrum of neuroimaging abnormalities in brain in patients of acute-on-chronic liver failure. J Clin Exp Hepatol, 2022, 12(2):343-352. [16] Idalsoaga F, Díaz LA, Fuentes-López E, et al. Active alcohol consumption is associated with acute-on-chronic liver failure in Hispanic patients. Gastroenterol Hepatol, 2024, 47(6):562-573. [17] Amorim JA, Coppotelli G, Rolo AP, et al. Mitochondrial and metabolic dysfunction in ageing and age-related diseases. Nat Rev Endocrinol, 2022, 18(4):243-258. [18] Wang XH, Peng BB, Zhang L, et al. Mixed mode of artificial liver support in patients with acute-on-chronic liver failure: a retrospective cohort study. Hepatol Int, 2023, 17(5):1241-1250. [19] Zhou J, Ye D, Zhang S, et al. Impact of donor diabetes mellitus status on liver transplant outcomes in patients with acute-on-chronic liver failure. Expert Rev Gastroenterol Hepatol, 2023, 17(5):509-517. [20] Artru F, Goldberg D, Kamath PS. Should patients with acute-on-chronic liver failure grade 3 receive higher priority for liver transplantation. J Hepatol, 2023, 78(6):1118-1123. [21] Yu X, Yang F, Shen Z, et al. BTLA contributes to acute-on-chronic liver failure infection and mortality through CD4+ T-cell exhaustion. Nat Commun, 2024, 15(1):1835-1842. [22] Elias G, Schonfeld M, Saleh S, et al. Sepsis-induced endothelial dysfunction drives acute-on-chronic liver failure through Angiopoietin-2-HGF-C/EBPβ pathway. Hepatology, 2023, 78(3):803-819. |